Novo Nordisk to buy Prothena’s heart drug in deal worth up to $1.2 bln
July 12 (Reuters) – Danish drugmaker Novo Nordisk (NOVOb.CO) will acquire U.S. drug developer Prothena Corp’s (PRTA.O) experimental heart therapy, PRX004, in a deal that could be worth up to $1.23 billion, the companies said on Monday. The acquisition is in line with Novo’s strategy to diversify its core insulin portfolio that has been facing tough competition, prompting it […]
The battle for the future of the US economy is being led by technology stocks!
The Nasdaq 100 Index outperformed, and the Stoxx 600 Index gained more than 1%, with technology stocks leading the way after a decline. Stockholders appeared to shake off inflation concerns that had frightened markets as new signs of skyrocketing inflation emerged. A commodity index hit a two-year high as copper prices surpassed $10,000 per tonne […]
